Adds to Drug Product Aseptic Formulation Development Expertise and Drug Product Manufacturing ALBANY, N.Y.–(BUSINESS WIRE)–July 13, 2021– Curia, formerly AMRI, a leading contract research, development ...
Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, and Humanigen, Inc. (NASDAQ:HGEN) (“Humanigen”), a ...
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Integrity Bio announces the validation of its second fill/finish manufacturing line. This plant expansion more than doubles the company’s manufacturing capacity ...
ALBANY, N.Y.--(BUSINESS WIRE)--Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced it has entered into a definitive agreement to acquire ...
SAN DIEGO and BURLINGAME, California, Jan. 27, 2021 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing ...
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced it has entered into a definitive agreement to acquire Integrity Bio, Inc., a privately ...
Aji Bio-Pharma will assume a key role in simplifying the supply chain efforts for Humanigen by providing drug product aseptic fill finish services at its San Diego facility to support continued ...
ALBANY, N.Y.--(BUSINESS WIRE)--#AMRI--Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced it has entered into a definitive agreement to ...
SAN DIEGO and BURLINGAME, Calif., Jan. 27, 2021 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results